Metformin protects against cardiac and renal damage in diabetic cardiac arrest patients.
Metformin protects against cardiac and renal damage in diabetic cardiac arrest patients.
复制标题
DOI:
10.1016/j.resuscitation.2022.03.017
复制
发表时间:
2022-05
期刊:
影响因子:
6.5
通讯作者:
Elmer, Jonathan
中科院分区:
文献类型:
--
作者:
Rutledge, Cody A.;Kaufman, Brett A.;Dezfulian, Cameron;Elmer, Jonathan
Metformin is a first-line diabetic therapy that improves survival in a wide number of ischemic pathologies. We tested the association of metformin with markers of cardiac and renal injury in diabetic post-arrest patients. We performed a retrospective analysis of clinical outcomes in diabetic cardiac arrest patients with and without metformin therapy at a single academic medical center. We used generalized linear models to test the independent association of metformin, insulin, and other hypoglycemic agents with peak 24-hour serum creatinine and peak 24-hour serum troponin. Metformin prescription at the time of SCA was independently associated with lower 24-hour peak serum troponin and lower 24-hour peak serum creatinine when compared to non-metformin patients. Metformin pretreatment may offer cardiac and renal protection for diabetic patients during sudden cardiac arrest.
登录
查看更多内容
影响因子:
8.1
作者:
Mongardon N;Dumas F;Ricome S;Grimaldi D;Hissem T;Pène F;Cariou A
通讯作者:
Cariou A
影响因子:
4.6
作者:
Li J;Gao L;Chen S;Tao K;Su Y;Wang T
通讯作者:
Wang T
影响因子:
16.9
作者:
Reitz, Katherine M.;Marroquin, Oscar C.;Neal, Matthew D.
通讯作者:
Neal, Matthew D.
影响因子:
6.5
作者:
Ruiz-Bailén, M;de Hoyos, EA;Fierro-Rosón, J
通讯作者:
Fierro-Rosón, J
影响因子:
7.7
作者:
Xie Z;Lau K;Eby B;Lozano P;He C;Pennington B;Li H;Rathi S;Dong Y;Tian R;Kem D;Zou MH
通讯作者:
Zou MH